D.E. Shaw & Co’s Meridian Bioscience Inc VIVO Stock Holding History

D.E. Shaw & Co’s Portfolio VIVO Stock Details VIVO Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,200	Closed	-$322K	–	3986
2022 Q3	$322K	Buy	+10,200	New	+$322K	﹤0.01%	3042
2021 Q2	–	Sell	-11,347	Closed	-$298K	–	3857
2021 Q1	$298K	Buy	+11,347	New	+$298K	﹤0.01%	2667
2020 Q4	–	Sell	-34,034	Closed	-$578K	–	2943
2020 Q3	$578K	Sell	34,034 -136,560	-80%	-$2.32M	﹤0.01%	2063
2020 Q2	$3.97M	Sell	170,594 -469,401	-73%	-$10.9M	﹤0.01%	1277
2020 Q1	$5.38M	Buy	639,995 +10,588	+2%	+$88.9K	0.01%	1033
2019 Q4	$6.15M	Sell	629,407 -10,399	-2%	-$102K	0.01%	1079
2019 Q3	$6.07M	Buy	639,806 +19,928	+3%	+$189K	0.01%	1053
2019 Q2	$7.36M	Buy	619,878 +235,171	+61%	+$2.79M	0.01%	982
2019 Q1	$6.78M	Buy	384,707 +467	+0.1%	+$8.22K	0.01%	1013
2018 Q4	$6.67M	Buy	384,240 +40,236	+12%	+$698K	0.01%	989
2018 Q3	$5.13M	Buy	344,004 +63,837	+23%	+$951K	0.01%	1122
2018 Q2	$4.46M	Buy	280,167 +80,960	+41%	+$1.29M	0.01%	1203
2018 Q1	$2.83M	Buy	199,207 +25,574	+15%	+$363K	﹤0.01%	1340
2017 Q4	$2.43M	Buy	173,633 +123,155	+244%	+$1.72M	﹤0.01%	1429
2017 Q3	$722K	Buy	50,478 +37,813	+299%	+$541K	﹤0.01%	1931
2017 Q2	$199K	Buy	12,665 +277	+2%	+$4.35K	﹤0.01%	2264
2017 Q1	$171K	Sell	12,388 -80,315	-87%	-$1.11M	﹤0.01%	2297
2016 Q4	$1.64M	Sell	92,703 -9,081	-9%	-$161K	﹤0.01%	1531
2016 Q3	$1.96M	Buy	101,784 +14,220	+16%	+$274K	﹤0.01%	1387
2016 Q2	$1.71M	Buy	87,564 +57,047	+187%	+$1.11M	﹤0.01%	1519
2016 Q1	$629K	Sell	30,517 -19,376	-39%	-$399K	﹤0.01%	1968
2015 Q4	$1.02M	Sell	49,893 -27,500	-36%	-$564K	﹤0.01%	1746
2015 Q3	$1.32M	Sell	77,393 -79,602	-51%	-$1.36M	﹤0.01%	1586
2015 Q2	$2.93M	Buy	156,995 +27,340	+21%	+$510K	﹤0.01%	1273
2015 Q1	$2.47M	Buy	129,655 +56,265	+77%	+$1.07M	﹤0.01%	1260
2014 Q4	$1.21M	Buy	73,390 +38,832	+112%	+$639K	﹤0.01%	1603
2014 Q3	$611K	Sell	34,558 -6,497	-16%	-$115K	﹤0.01%	1760
2014 Q2	$847K	Sell	41,055 -52,354	-56%	-$1.08M	﹤0.01%	1663
2014 Q1	$2.04M	Buy	+93,409	New	+$2.04M	﹤0.01%	1250